Venous thromboembolism in ovarian cancer patients receiving erythropoietin (Epo)/darbepoetin (Darbe) for chemotherapy-induced anemia (CIA)

16514 Background: Cancer patients are at higher risk of developing venous thromboembolism (VTE) than the general population. With VTE incidence of 5.2% - 5.6%, ovarian cancer ranks third among mali...